Find Clinical Trials & Studies

Visit the Research & Education Institute

Research Study to Evaluate an Investigational Treatment Study for Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection

I'm Interested!

A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects with Cystic Fibrosis and Chronic Pseudomonas aeruginosa Lung Infection

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Lung, Cystic Fibrosis (CF)

Study Purpose

The main purpose of this study is to see whether inhaling this combination of drugs in RSP 1502 has an acceptable safety profile and works better compared to inhaling tobramycin alone when treating participants with CF and chronic Pseudomonas aeruginosa lung infection.

Who Can Participate

Age: 18 years and older

Principal Investigator
Alex Gifford MD

Department/Division
Pediatrics (Pulmonology)

Locations

UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106

Get Directions

UH IRB: SITE00002058
StudyID: 2023-01232
ClinicalTrials.gov: NCT06016088

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422